+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela



BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela



Biological Research 45(2): 117-130



A sample of 58 familial breast cancer patients from Venezuela were screened for germline mutations in the coding sequences and exon-intron boundaries of BRCA1 (MIM no. 113705) and BRCA2 (MIM no. 600185) genes by using conformation-sensitive gel electrophoresis. Ashkenazi Jewish founder mutations were not found in any of the samples. We identified 6 (10.3%) and 4 (6.9%) patients carrying germline mutations in BRCA1 and BRCA2, respectively. Four pathogenic mutations were found in BRCA1, one is a novel mutation (c.951_952insA), while the other three had been previously reported (c.1129_1135insA, c.4603G>T and IVS20+1G>A). We also found 4 pathogenic mutations in BRCA2, two novel mutations (c.2732_2733insA and c.3870_3873delG) and two that have been already reported (c.3036_3039delACAA and c.6024_6025_delTA). In addition, 17 variants of unknown significance (6 BRCA1 variants and 11 BRCA2 variants), 5 BRCA2 variants with no clinical importance and 22 polymorphisms (12 in BRCA1 and 10 in BRCA2) were also identified. This is the first genetic study on BRCA gene mutations conducted in breast cancer patients from Venezuela. The ethnicity of our population, as well as the heterogeneous and broad spectrum of BRCA genes mutations, must be considered to optimize genetic counseling and disease prevention in affected families.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051744332

Download citation: RISBibTeXText

PMID: 23096355

DOI: 10.4067/S0716-97602012000200003


Related references

BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations. Journal of Clinical Oncology 17(10): 3017-3024, 1999

Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes & Development 11(10): 1226-1241, 1997

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Clinical Cancer Research 9(10 Pt 1): 3606-3614, 2003

BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity. Medical Oncology 29(5): 3272-3281, 2013

Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients. Breast Cancer Research and Treatment 107(3): 431-441, 2007

BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations. Cancer Letters 245(1-2): 90-95, 2006

ATM germline mutations in Spanish early-onset breast cancer patients negative for BRCA1/BRCA2 mutations. Clinical Genetics 73(5): 465-473, 2008

PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations. Breast Cancer Research and Treatment 122(1): 303-306, 2010

BRCA1 and BRCA2 mutations in Korean breast cancer patients. Breast Cancer Research & Treatment 82(Supplement 1): S77-S78, 2003

BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines. International Journal of Cancer 98(4): 596-603, 1 April, 2002

BRCA1 and BRCA2 mutations in patients with familial breast cancer. Medicina Clinica 124(1): 10-12, 2005

Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Research and Treatment 88(2): 177-186, 2004

Germline BRCA1 and BRCA2 mutations in patients with breast/ovarian cancer or with breast fibroadenoma and familial cancer history. Proceedings of the American Association for Cancer Research Annual Meeting 42: 731, March, 2001

BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients. British Journal of Cancer 83(6): 737-742, 2000